Malignant pleural effusion cells show aberrant glucose metabolism gene expression

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1453-1465

  Lin, C C ^a   Chen, L C ^b   Tseng, V S ^b   Yan, J J ^a   Lai, W W ^a   Su, W P ^a   Lin, C H ^c   Huang, C Y F ^c   Su, W C ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Glucose metabolism genes; Lung adenocarcinoma; Malignant pleural effusion

Indexed keywords

FRUCTOSE BISPHOSPHATE ALDOLASE A; IDITOL DEHYDROGENASE; LYASE; MEMBRANE PROTEIN; MESSENGER RNA; OXYTHIAMINE; SMALL INTERFERING RNA; THYROID TRANSCRIPTION FACTOR 1; TRANSKETOLASE; TUBEROUS SCLEROSIS 1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ALDOA GENE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLEURA EFFUSION; PLEURA METASTASIS; PRIORITY JOURNAL; PROTEIN SECRETION; SORD GENE; TKT GENE; TSC1 GENE; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; CELL PROLIFERATION; COHORT STUDIES; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HUMANS; L-IDITOL 2-DEHYDROGENASE; LUNG NEOPLASMS; MIDDLE AGED; NUCLEAR PROTEINS; PLEURAL EFFUSION, MALIGNANT; TRANSCRIPTION FACTORS; TRANSKETOLASE; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79957975024     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00015710     Document Type: Article

References (39)

1. Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med 2005; 172: 523-529. (Pubitemid 41232963)
2. Coscio AM, Garst J. Lung cancer in women. Curr Oncol Rep 2006; 8: 248-251. (Pubitemid 43970975)
3. Trompezinski S, Denis A, Schmitt D, et al. IL-10 is unable to downregulate VEGF expression in human activated keratinocytes. Arch Dermatol Res 2002; 294: 377-379. (Pubitemid 35341031)
4. Wu SG, Gow CH, Yu CJ, et al. Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma. Eur Respir J 2008; 32: 924-930.
5. Postmus PE, Brambilla E, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2: 686-693. (Pubitemid 47357520)
6. Kassis J, Klominek J, Kohn EC. Tumor microenvironment: what can effusions teach us? Diagn Cytopathol 2005; 33: 316-319.
7. Zebrowski BK, Yano S, Liu W, et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 1999; 5: 3364-3368.
8. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120: 56-64. (Pubitemid 24011502)
9. Yeh HH, Lai WW, Chen HH, et al. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 2006; 25: 4300-4309. (Pubitemid 44100500)
10. Chen YM, Tsai CM, Whang-Peng J, et al. Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes. Chest 2002; 122: 1421-1427.
11. Su LJ, Chang CW, Wu YC, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genom 2007; 8: 140.
12. American Joint Committee on Cancer. Manual for Staging of Cancer. 5th Edn. Philadelphia, JB Lippincott, 1997.
13. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
14. Landsittel D, Donohue-Babiak N. Effect of adding fold-change criteria to significance testing of microarray data. J Statist Comput Simul 2010; 80: 89-97.
15. Kerstens HM, Robben JC, Poddighe PJ, et al. AgarCyto: a novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix. J Histochem Cytochem 2000; 48: 709-718. (Pubitemid 30233195)
16. Al-Shahrour F, Minguez P, Tarraga J, et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic acids research 2006; 34: W472-W476. (Pubitemid 44529816)
17. Jimenez-Marin A, Collado-Romero M, Ramirez-Boo M, et al. Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. BMC Proc 2009; 3: Suppl. 4, S6.
18. Barnes DM, Harris WH, Smith P, et al. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Brit J Cancer 1996; 74: 1445-1451. (Pubitemid 26370738)
19. Gomez-Fernandez C, Jorda M, Delgado PI, et al. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids. Cancer 2002; 96: 289-293. (Pubitemid 35221616)
20. Szczepulska-Wojcik E, Langfort R, Roszkowski-Sliz K. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation]. Pneumonol Alergol Pol 2007; 75: 57-69.
21. Chen YF, Chou CY, Wilkins RJ, et al. Motor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasion. Cancer Res 2009; 69: 8585-8593.
22. Rais B, Comin B, Puigjaner J, et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett 1999; 456: 113-118. (Pubitemid 29339052)
23. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
24. Sanchez-Armengol A, Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993; 104: 1482-1485. (Pubitemid 23327868)
25. Duysinx B, Corhay JL, Larock MP, et al. Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion. Nucl Med Commun 2008; 29: 982-986.
26. Langbein S, Zerilli M, Zur Hausen A, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival:Warburg effect reinterpreted. Brit J Cancer 2006; 94: 578-585. (Pubitemid 43289763)
27. Tammali R, Ramana KV, Srivastava SK. Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett 2007; 252: 299-306. (Pubitemid 46823949)
28. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472-482. (Pubitemid 351766797)
29. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005-3015. (Pubitemid 28254373)
30. Lutz NW, Tome ME, Cozzone PJ. Early changes in glucose and phospholipid metabolism following apoptosis induction by IFN-γ/TNF-α in HT-29 cells. FEBS Lett 2003; 544: 123-128. (Pubitemid 36628047)
31. Stathopoulos GT, Kollintza A, Moschos C, et al. Tumor necrosis factor-alpha promotes malignant pleural effusion. Cancer Res 2007; 67: 9825-9834. (Pubitemid 47621230)
32. Hunt TK, Aslam R, Hussain Z, et al. Lactate, with oxygen, incites angiogenesis. Adv Exp Med Biol 2008; 614: 73-80.
33. Ojika T, Imaizumi M, Watanabe H, et al. [An immunohistochemical study on three aldolase isozymes in human lung cancer]. Zasshi J 1992; 40: 382-386.
34. Mori S, Chang JT, Andrechek ER, et al. Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 2009; 28: 2796-2805.
35. Zhang X, Xu LH, Yu Q. Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth. Mol Cancer 2010; 9: 7.
36. Katare R, Andrea C, Emanueli C, et al. Benfotiamine improves functional recovery of the infarcted heart via activation of prosurvival G6PD/Akt signaling pathway and modulation of neurohormonal response. J Mol Cell Cardiol 2010; 49: 625-638.
37. Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005; 14: R251-R258. (Pubitemid 41631882)
38. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007; 448: 807-810. (Pubitemid 47266337)
39. Lee DF, Kuo HP, Chen CT, et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007; 130: 440-455.